Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease - PubMed (original) (raw)
. 2008 Oct;31(10):2003-5.
doi: 10.2337/dc08-0688. Epub 2008 Jul 3.
Affiliations
- PMID: 18599528
- PMCID: PMC2551644
- DOI: 10.2337/dc08-0688
Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease
Jane A Driver et al. Diabetes Care. 2008 Oct.
Abstract
Objective: To evaluate the association between type 2 diabetes and newly reported Parkinson's disease.
Research design and methods: Our study included 21,841 participants in the Physicians' Health Study, a cohort of U.S. male physicians. Diabetes and Parkinson's disease were self-reported via questionnaire. We used time-varying Cox regression to calculate adjusted relative risk (RR) for Parkinson's disease.
Results: Over 23 years, 556 individuals with Parkinson's disease were identified. Subjects with diabetes had an increased Parkinson's disease risk (multivariable-adjusted RR 1.34 [95% CI 1.01-1.77]). The association remained significant after exclusion of those with known vascular disease. The diagnosis of diabetes was clustered around the diagnosis of Parkinson's disease and was more apparent among men with short diabetes duration and those without complications from diabetes.
Conclusions: Results of this large prospective study in men do not suggest that diabetes is a preceding risk factor for Parkinson's disease. Whether the positive association may be explained by ascertainment bias or a common underlying biological mechanism remains to be established.
Similar articles
- Type 2 diabetes and the risk of Parkinson's disease.
Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J. Hu G, et al. Diabetes Care. 2007 Apr;30(4):842-7. doi: 10.2337/dc06-2011. Epub 2007 Jan 24. Diabetes Care. 2007. PMID: 17251276 - Smoking and the risk of hemorrhagic stroke in men.
Kurth T, Kase CS, Berger K, Schaeffner ES, Buring JE, Gaziano JM. Kurth T, et al. Stroke. 2003 May;34(5):1151-5. doi: 10.1161/01.STR.0000065200.93070.32. Epub 2003 Mar 27. Stroke. 2003. PMID: 12663877 - Diabetes medications and risk of Parkinson's disease: a cohort study of patients with diabetes.
Brauer R, Wei L, Ma T, Athauda D, Girges C, Vijiaratnam N, Auld G, Whittlesea C, Wong I, Foltynie T. Brauer R, et al. Brain. 2020 Oct 1;143(10):3067-3076. doi: 10.1093/brain/awaa262. Brain. 2020. PMID: 33011770 Free PMC article. - Sex Disparities in Cardiovascular Outcome Trials of Populations With Diabetes: A Systematic Review and Meta-analysis.
Clemens KK, Woodward M, Neal B, Zinman B. Clemens KK, et al. Diabetes Care. 2020 May;43(5):1157-1163. doi: 10.2337/dc19-2257. Diabetes Care. 2020. PMID: 32312859 - GLP-1 receptor agonists for Parkinson's disease.
Mulvaney CA, Duarte GS, Handley J, Evans DJ, Menon S, Wyse R, Emsley HC. Mulvaney CA, et al. Cochrane Database Syst Rev. 2020 Jul 23;7(7):CD012990. doi: 10.1002/14651858.CD012990.pub2. Cochrane Database Syst Rev. 2020. PMID: 32700772 Free PMC article.
Cited by
- Associations between cerebrovascular risk factors and parkinson disease.
Kummer BR, Diaz I, Wu X, Aaroe AE, Chen ML, Iadecola C, Kamel H, Navi BB. Kummer BR, et al. Ann Neurol. 2019 Oct;86(4):572-581. doi: 10.1002/ana.25564. Epub 2019 Aug 29. Ann Neurol. 2019. PMID: 31464350 Free PMC article. - Cardiovascular Risk Factors and Phenoconversion to Neurodegenerative Synucleinopathies in Idiopathic REM Sleep Behavior Disorder.
Zolfaghari S, Lewandowski N, Pelletier A, Naeimi SA, Gagnon JF, Brillon-Corbeil M, Montplaisir JY, Postuma RB. Zolfaghari S, et al. J Parkinsons Dis. 2022;12(3):927-933. doi: 10.3233/JPD-212984. J Parkinsons Dis. 2022. PMID: 35001898 Free PMC article. - Type 2 Diabetes (T2DM) and Parkinson's Disease (PD): a Mechanistic Approach.
Sabari SS, Balasubramani K, Iyer M, Sureshbabu HW, Venkatesan D, Gopalakrishnan AV, Narayanaswamy A, Senthil Kumar N, Vellingiri B. Sabari SS, et al. Mol Neurobiol. 2023 Aug;60(8):4547-4573. doi: 10.1007/s12035-023-03359-y. Epub 2023 Apr 28. Mol Neurobiol. 2023. PMID: 37118323 Free PMC article. Review. - Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences.
Sergi D, Renaud J, Simola N, Martinoli MG. Sergi D, et al. Front Aging Neurosci. 2019 Nov 8;11:302. doi: 10.3389/fnagi.2019.00302. eCollection 2019. Front Aging Neurosci. 2019. PMID: 31787891 Free PMC article. - Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson's Disease: Insights into Mechanisms and Pathological Consequences.
Xxxx S, Ahmad MH, Rani L, Mondal AC. Xxxx S, et al. Mol Neurobiol. 2022 Jul;59(7):4466-4487. doi: 10.1007/s12035-022-02867-7. Epub 2022 May 16. Mol Neurobiol. 2022. PMID: 35575870 Review.
References
- Sandyk R: The relationship between diabetes mellitus and Parkinson's disease. Int J Neurosci 69:125–130, 1993 - PubMed
- Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J: Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 30:842–847, 2007 - PubMed
- Lipman IJ, Boykin ME, Flora RE: Glucose intolerance in Parkinson's disease. J Chronic Dis 27:573–579, 1974 - PubMed
- Pressley JC, Louis ED, Tang MX, Cote L, Cohen PD, Glied S, Mayeux R: The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism. Neurology 60:87–93, 2003 - PubMed
- Powers KM, Smith-Weller T, Franklin GM, Longstreth WT Jr, Swanson PD, Checkoway H: Diabetes, smoking, and other medical conditions in relation to Parkinson's disease risk. Parkinsonism Relat Disord 12:185–189, 2006 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- CA-40360/CA/NCI NIH HHS/United States
- CA-34944/CA/NCI NIH HHS/United States
- HL-34595/HL/NHLBI NIH HHS/United States
- HL-26490/HL/NHLBI NIH HHS/United States
- R01 HL026490/HL/NHLBI NIH HHS/United States
- CA-097193/CA/NCI NIH HHS/United States
- R01 CA040360/CA/NCI NIH HHS/United States
- R01 CA097193/CA/NCI NIH HHS/United States
- R01 CA034944/CA/NCI NIH HHS/United States
- T35 AG026781/AG/NIA NIH HHS/United States
- R01 HL034595/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical